|
The Institute of Molecular Biotechnology (IMBA) is an independent research organisation founded as a joint initiative of the Austrian Academy of Sciences in cooperation with the company Boehringer Ingelheim an international pharmaceutical company with headquarters in Germany. IMBA operates in close collaboration with the Research Institute of Molecular Pathology, Boehringer's basic research center both located next to each other at the (Campus Vienna Biocenter ) (VBC). ==Main Research Areas== IMBA’s vision is to understand the fundamental molecular mechanism in molecular biological processes and currently focus in cell biology, RNA interference, and epigenetics research performed by independent research groups. The topics actually addressed at the institute are: *Bones, Immunity and Cancer (Josef Penninger) *Epigenetic Regulation by the Polycomb and Trithorax group proteins (Leonie Ringrose) *The piRNA Pathway in the Drosophila Germline - an RNA based Genome Immune System (Julius Brennecke) *Mechanisms of RNA silencing in human cell (Javier Martínez) *Editing the Epigenome: Plasticity and Memory of Chromatin Structure (Oliver Bell) *Asymmetric cell division and proliferation control in Drosophila (Jürgen Knoblich) *RNA-directed DNA elimination in Tetrahymena (Kazufumi Mochizuki) *Design and function of molecular machines (Thomas Marlovits) * Mechanism and Biology of RNA Silencing (Stefan Ameres) * Cytoskeletal and membrane dynamics in cell division (Daniel Gerlich) * Inflammatory regulation by ubiquitin networks (Fumiyo Ikeda) * Molecular control of the oocyte-to-zygote transition (Kikue Tachibana-Konwalski) * Mechanisms underlying cell motility and guidance (Emeritus Group: Vic Small) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Institute of Molecular Biotechnology」の詳細全文を読む スポンサード リンク
|